cell pharm GmbH Company Profile

05:31 EDT 29th July 2015 | BioPortfolio

Nil

Contact

Email: info@cellpharm.com


News Articles [1092 Associated News Articles listed on BioPortfolio]

Chinese regulator approves D-Pharm epilepsy drug trial

D-Pharm has teamed with China's Nhwa Pharmaceutical in developing DP-VPA.

Bukwang Pharm Appoints Korea's First Woman CEO

Yu Hee-won has been appointed as co-president and CEO of Korean-based Bukwang Pharm.

Re-Pharm identifies novel anti-inflammatory activity for existing compound

Re-Pharm, an early-stage drug discovery and development company based on the principles of compound re-profiling, is pleased to announce the identification of RP0217 as an effective new anti-inflammat...

Re-Pharm Uses Cresset’s Forge to Identify Novel Activity for an Existing Drug

Cresset, innovative provider of computational chemistry software and services, announces that its drug discovery arm Re-Pharm Ltd has used Forge to identify novel anti-inflammatory activity for an exi...

Russia’s R-Pharm in deals with AbbVie and Bristol-Myers for local production

US drugmaker AbbVie has joined forces with Russia’s R-Pharm to establish the joint production of Kaletra…

Gilead Honored at Pharm Exec Brand of the Year Event

The company picked up the Pharm Exec Brand of the Year award last week at the iPharma event in New York. Date:  Wed, 2015-05-20 (All day) ...

Green Cross, Daewoong Diverge In Global Expansion Push

Two leading South Korean pharma firms are moving in different directions as they aim to expand globally, with Daewoong Pharm agreeing to buy a controlling stake in HanAll BioPharma, while Green Cross ...

Daewoong Eyes Entry Into China Stem Cell Sector

After a licensing deal with stem cell company Kang Stem Biotech a few months ago, Daewoong Pharm is now accelerating its efforts to expand in the sector internationally through a deal for the Chinese ...

PubMed Articles [4006 Associated PubMed Articles listed on BioPortfolio]

Cover picture: arch. Pharm. Chem. Life sci. (1/2015).

Editorial board: arch. Pharm. Chem. Life sci. (1/2015).

Unbound Ritonavir Concentrations in Rat and Human Hepatocytes.

Knowledge regarding intracellular drug exposure is crucial to gain mechanistic understanding of hepatic disposition. This study aims to develop an approach to determine unbound intracellular concentra...

In vitro cytotoxicity and in vivo efficacy, pharmacokinetics, and metabolism of pyrazole-based small molecule inhibitors of Mdm2/4-p53 interaction.

The interaction of p53 with its negative regulators Mdm2/4 has been widely studied (Khoury and Domling in Curr Pharm Des 18(30):4668-4678, 2012). In p53(+/+) cells, expression of Mdm2/4 leads to p53 t...

SIRT1 Synchs Satellite Cell Metabolism with Stem Cell Fate.

Metabolic reprogramming of muscle stem cells modulates myogenic cell fate. In this issue of Cell Stem Cell, Ryall et al. (2015) show that SIRT1, a NAD(+)-dependent histone deacetylase, acts as an epi...

Clinical Trials [3465 Associated Clinical Trials listed on BioPortfolio]

A Study of GDC-0853 in Patients With Resistant B-Cell Lymphoma or Chronic Lymphocytic Leukemia.

This open-label, Phase I study will evaluate the safety, tolerability, and pharm acokinetics of increasing doses of GDC-0853 in patients with relapsed or refract ory B-cell non-Hodgkin's l...

Trial of Belotecan/Cisplatin in Chemotherapy Naive Small Cell Lung Cancer Patient

Belotecan (Camtobell, CKD-602, Chong Kun Dang Pharm., Korea) is a new camptothecin derivative, that exhibits anticancer effects by inhibiting topoisomerase I. The investigators will have a...

Comparison Study of Intravenous (IV) Versus Oral Iron (Fe) for Iron Deficiency Anemia Treatment in Late Pregnancy

The purpose of this study is to compare the efficacy of treatment between intravenous iron sucrose and oral iron fumarate in pregnant women in the third trimester.

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

Cognitive Adaptive Training for Improving Medication Adherence, Symptoms, and Function in People With Schizophrenia

This study will compare the effectiveness of three treatments in improving medication adherence, symptoms, and function in people with schizophrenia.

Companies [915 Associated Companies listed on BioPortfolio]

NP Pharm

Founded in January 1992, NP Pharm is a private company, part of the Pharmaceutical group ETHYPHARM, which is one of the world leading companies for Drug Delivery Systems (DDS). Based, on a large exper...

cell pharm GmbH

Nil

Beijing Med-Pharm Corp

Beijing Med-Pharm offers an end-to-end solution to U.S and western pharmaceutical companies wishing to sell their products in China. We offer sales and marketing services throughout China and can help...

Pharm-Chem

Pharm-Chem.com is a special directory of the chemical and medicine industries, offering up-to-date information of China chemical and medicine manufacturers and suppliers as well as the news and the la...

Pharm PlanNet Contract Research GmbH

Pharm PlanNet Contract Research GmbH (Pharm PlanNet) was founded in 1992 as an independent and privately owned Clinical Research Organisation offering its service to the pharmaceutical industry. Pharm...

More Information about "cell pharm GmbH" on BioPortfolio

We have published hundreds of cell pharm GmbH news stories on BioPortfolio along with dozens of cell pharm GmbH Clinical Trials and PubMed Articles about cell pharm GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of cell pharm GmbH Companies in our database. You can also find out about relevant cell pharm GmbH Drugs and Medications on this site too.


Advertisement
 
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record